Elekta changes outlook for 2019/20 and addresses challenges related to COVID-19
STOCKHOLM, April 28, 2020 – As a result of the impact of the COVID-19 pandemic on our last quarter (ending April 30), Elekta (EKTA-B.ST) changes the outlook for the fiscal year 2019/20. We expect net sales growth of around 1 percent compared to last year based on constant currency, and an EBITA margin between 16 and 17 percent. Due to ongoing uncertainties related to the development of the COVID-19 pandemic, we also withdraw our scenario for 2020/21 to 2022/23. An updated outlook will be published when we can further quantify the impact of COVID-19 on the radiation therapy market and the